Restoration of epithelial cell polarity in a colorectal cancer cell line by suppression of β-catenin/T-cell factor 4-mediated gene transactivation

Cancer Research

Volumn 61, Issue 6, 2001, Pages 2751-2758

  Naishiro, Yasuyoshi ^a,b   Yamada, Tesshi ^a   Takaoka, Asako S ^a,b   Hayashi, Reiko ^a   Hasegawa, Fumio ^a   Imai, Kohzoh ^b   Hirohashi, Setsuo ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; DNA BINDING PROTEIN; GAP JUNCTION PROTEIN; LYMPHOID ENHANCER FACTOR 4; PROTEIN ZO1; SULINDAC; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL POLARITY; COLON CARCINOGENESIS; COLON MUCOSA; COLORECTAL CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; MICROVILLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TIGHT JUNCTION; TRANSACTIVATION; TUMOR SUPPRESSOR GENE;

ADENOCARCINOMA; AMINO ACID SEQUENCE; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA CATENIN; CELL DIVISION; CELL MEMBRANE; CELL POLARITY; COLORECTAL NEOPLASMS; CYTOSKELETAL PROTEINS; DOXYCYCLINE; EPITHELIAL CELLS; GENES, MDR; HUMANS; INTESTINAL MUCOSA; MEMBRANE PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; RATS; RETROVIRIDAE; SULINDAC; TCF TRANSCRIPTION FACTORS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035866801     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients
2. Identification and characterization of the familial adenomatous polyposis coli gene
3. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene
4. Somatic mutations of the APC gene in colorectal tumors: Mutation cluster region in the APC gene
5. APC mutations occur early during colorectal tumorigenesis
6. Lessons from hereditary colorectal cancer
7. Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene
8. The role of the adenomatous polyposis coli (APC) gene in human cancers
9. The adenomatous polyposis coli (APC) tumor suppressor
10. β-Catenin is a target for the ubiquitin-proteasome pathway
11. Regulation of β-catenin levels and localization by overexpression of plakoglobin and inhibition of the ubiquitin-proteasome system
12. Functional interaction of an axin homolog, conductin, with β-catenin, APC, and GSK3β
13. Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
14. Stabilization of β-catenin by genetic defects in melanoma cell lines
15. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
16. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin
17. Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer
18. β-Catenin is frequently mutated and demonstrates altered cellular location in azoxymethane-induced rat colon tumors
19. High frequency of β-catenin (ctnnb1) mutations in the colon tumors induced by two heterocyclic amines in the F344 rat
20. Intestinal polyposis in mice with a dominant stable mutation of the β-catenin gene
21. From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion
22. Inactivation of the E-cadherin-mediated cell adhesion system in human cancers
23. Functional interaction of β-catenin with the transcription factor LEF-1
24. Nuclear localization of β-catenin by interaction with transcription factor LEF-1
25. Armadillo coactivates transcription driven by the product of the Drosophila segment polarity gene dTCF
26. Constitutive transcriptional activation by a β-catenin-Tcf complex in APC-/- colon carcinoma
27. Identification of c-MYC as a target of the APC pathway
28. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
29. The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway
30. The metalloproteinase matrilysin is a target of β-catenin transactivation in intestinal tumors
31. β-Catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer
32. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs
33. Synergy between tumor suppressor APC and the β-catenin-Tcf4 target Tcf1
34. Transactivation of the multidrug resistance 1 gene by T-cell factor 4/β-catenin complex in early colorectal carcinogenesis
35. Epithelioid cell cultures from rat small intestine
36. Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion
37. The pCL vector system: Rapid production of helper-free, high-titer, recombinant retroviruses
38. Transcriptional activation by tetracyclines in mammalian cells
39. Morphogenesis of the polarized epithelial cell phenotype
40. Differential behavior of E-cadherin and occludin in their colocalization with ZO-1 during the establishment of epithelial cell polarity
41. Target genes of β-catenin-T cell-factor/lymphoid-enhancer-factor signaling in human colorectal carcinomas
42. Expression of occludin, tight-junction-associated protein, in human digestive tract
43. Sulindac causes regression of rectal polyps in familial adenomatous polyposis
44. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis
45. Deletion of an amino-terminal sequence β-catenin in vivo and promotes hyperphosphorylation of the adenomatous polyposis coli tumor suppressor protein
46. 2-terminal deletion of β-catenin results in stable colocalization of mutant β-catenin with adenomatous polyposis coli protein and altered MDCK cell adhesion
47. Changes of proliferative activity and phenotypes in spontaneous differentiation of a colon cancer cell line
48. Inhibition of adipogenesis by wnt signaling
49. Transformation and morphological changes of murine L cells by transfection with a mutated form of β-catenin
50. Exogenous expression of β-catenin regulates contact inhibition, anchorage-independent growth, anoikis, and radiation-induced cell cycle arrest
51. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis
52. Sulindac causes rapid regression of preexisting tumors in Min/+ mice independent of prostaglandin biosynthesis
53. Cyclooxygenase-2: The future is now
54. Cyclooxygenase-2 inhibitors in tumorigenesis (part I)
55. Δ716 knockout mice